Challenges and Possibilities in Intellectual Disability Medicine The genetic etiology may help in the treatment of epilepsies
|
|
- Ethelbert Griffith
- 6 years ago
- Views:
Transcription
1 Challenges and Possibilities in Intellectual Disability Medicine The genetic etiology may help in the treatment of epilepsies Thomas Dorn Helsinki, 15th November 2013
2 Overview Principles of epilepsy therapy Remarks on classification and genetic of epilepsies Avoidance of «wrong» antiepileptic drugs (AED) Progressive myoclonic epilepsies (PME) Dravet`s syndrome Special AED for special syndromes Dravet s syndrom Tuberous sclerosis Syndrome specific disease modifying therapies GLUT1-Defekt Tuberous sclersosis Diagnosis of genetic syndromes Summary, Perspectives 2
3 Principles of Epilepsy Therapy Antiepileptic (anticonvulsive) drugs (AED) = suppression of seizures Epilepsy surgery sensu strictu = resection of a localised residual epileptogenic brain pathology: seizure freedom at least with AED Additional treatment of a progressive brain disease (e.g. brain tumor, herpes encephalitis, angioma) Treatment of underlying brain disease only (e.g. limbic encephalitis with LGI1 antibodies) 3
4 Classification and Genetics of Epilepsies Idiopathic (genetic) (genetisch) cryptogenic (= probably symptomatic) symptomatic focal genetic ( oligogenic?) rarely monogenic in part genetic in part genetic generalised genetic ( oligogenic?) rarely monogenic) in part genetic In part genetic Monogenic idiopathic or symptomatic epilepsies incl. mitochiondrial cytopathies (about 1% of all epilepsies) gene proteine pathophysiology? specific therapy? 4
5 PME Differential Diagnosis seizures + myoclonia + ataxia + cognitive decline progressive myoclonic epilepsies Unverricht-Lundborg Lafora Sialidosis Ceroidlipofuscinosis MERRF DPRLA others Clarification of underlying entity by anamnesis, physical examination, EEG, evoked potentials, biopsy and molecular genetics 5
6 PME- Differential Therapy of AED Phenytoine can cause irreversible increase of neurological symptoms (ataxia) in Unverricht Lundborg disease Berkovic SF, Cochius J, Andermann E et al. Epilepsia 1993; 34 Suppl 3: S19 - S30 Valproate can cause severe liver failure in mitochondrial cytopathies (e.g. MERRF, POLG) Krähenbühl S, Brandner S, Kleinle S et al. Liver 2000; 20: (Topiramate may exert positive effects in mitochondrial cytopathies) Kudin AP, Debska-Vielhaber G,Vielhaber S. et al. Epilepsia 2004;45:
7 Dravet s Syndrome (SMEI) Phenotype/Genotype 7
8 Dravet s Syndrome (SMEI) Phenotype/Genotype 8
9 Dravet s Syndrome (SMEI)- Proteine More severe phenotype of GEFS+/SMEI with mutations affecting the pore region? Kanai K et al. Neurology 2004; 63:
10 Dravet s Syndrome (SMEI)- Pathophysiology GEFS+/SMEI with gain of function mutations of SCN1A Rhodes, Thomas H. et al. Proc. Natl. Acad. Sci. USA 2004; 101:
11 Dravet s Syndrome (SMEI)- Pathophysiology GEFS+/SMEI with loss of function mutations of SCNA1 Lossin C et al. J Neurosci 2003;23: GEFS+ with SCNA1 mutations causing impaired channel function Barela AJ et al. J Neurosci 2006; 26: Activation Fast inactivation 11
12 Dravet s Syndrome (SMEI)- Pathophysiology SMEI with non truncating mutations is associated with impaired transport of dysfunctional channel proteins to cell surface, LTG increases pathological sodium current Thomson Ch et al. J Biol Chem. 2012; 287:
13 Dravet s Syndrome (SMEI)- Avoidance of Certain AED Prognostic, clinical and demographic features in SCN1A mutationpositive Dravet syndrome. Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Dravet syndrome is a severe infantile onset epileptic encephalopathy associated with mutations in the sodium channel alpha 1 subunit gene SCN1A. To date no large studies have systematically examined the prognostic, clinical and demographic features of the disease. We prospectively collected data on a UK cohort of individuals with Dravet syndrome during a 5-year study period and analysed demographic information based on UK population and birth figures. From structured referral data we examined a range of clinical characteristics including epilepsy phenotype, seizure precipitants, electroencephalography data, imaging studies, mutation class and response to medication. Predictors of developmental outcome were determined by logistic regression. We identified 241 cases with SCN1A mutation-positive Dravet syndrome, 207 of which were UK-based. The incidence of mutation-positive Dravet syndrome is at least 1: UK births. Clinical features predicting a worse developmental outcome included status epilepticus (odds ratio = 3.1; confidence interval = ; P = 0.003), interictal electroencephalography abnormalities in the first year of life (odds ratio = 5.7; confidence interval = ; P = 0.002) and motor disorder (odds ratio = 3.3; confidence interval = ; P < 0.001). No significant effect was seen for seizure precipitants, magnetic resonance imaging abnormalities or mutation class (truncating versus missense). Abnormal magnetic resonance imaging was documented in 11% of cases, principally with findings of nonspecific brain atrophy or hippocampal changes. Sodium valproate, benzodiazepines and topiramate were reported as being the most helpful medications at the time of referral. Aggravation of seizures was reported for carbamazepine and lamotrigine. The identification of factors influencing prognosis both aids counselling and encourages early, syndromespecific therapy. Prevention of status epilepticus with regular medication and emergency protocols is important and may influence developmental outcome. Brain. 2012; 135:
14 Dravet s Syndrome (SMEI)- specific therapy mode of action: lengthening of duration of the open state of GABA A receptor chloride channel complexes via allosteric PB binding site no direct interaction with benzodiazepines Cave: pharmakokinetic interactions Chiron C. Expert Opin. Investig. Drugs 2005; 14:
15 Dravet s Syndrome (SMEI)- specific therapy?? Chiron C. Expert Opin. Investig. Drugs 2005; 14:
16 Dravet s Syndrome (SMEI)- specific therapy Avoid LTG, CBZ, PB (in high dose, iv) Stiripentol as orphan drug with VPA plus CLB TPM, LEV, bromide und ketogenic diet Chiron C. Developmental Medicine & Child Neurology 2011; 53:
17 GLUT1 Defect Phenotype, Pathophysiology and Specific therapy New England Journal of Medicine 1991; 325:
18 GLUT1 Defect - Genotype Mutations of SLC2A1 cause impairment of glucose transport autosomal rezessive and autosomal dominant inheritance Kollros PR, Konkle BA (1992) A candidate mutation in the GLUT-1 gene in a patient with glucose transporter dysfunction at the blood brain barrier (abstract). Ann Neurol 32:445 Kollros PR, Konkle BA (1993) A second candidate mutation in a patient with glucose transporter-1 dysfunction (abstract). Clin Res A Seidner G, Garcia Alvarez M, Yeh J-I, O'Driscoll KR, Klepper J, Stump TS, Wang D, Spinner NB, Birnbaum MJ, De Vivo DC (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18: The Journal of Clinical Investigation 2008; 118:
19 GLUT1 Defect Expanding the Phenotype The Journal of Clinical Investigation 2008; 118:
20 GLUT1 Defect Expanding the Phenotype 20
21 GLUT1 Defect Expanding the Phenotype 21
22 GLUT1 Defect Expanding the Phenotype 22
23 GLUT1 Defect Expanding the Phenotype 23
24 GLUT1 Defect Expanding the Phenotype 24
25 GLUT1 Defect Expanding the Phenotype 25
26 Tuberous Sclerosis Phenotype and Genotype neurocutaneous, genetic syndrome autosomal-dominant inheritance typic tumorous manifestations in CNS, skin and viscera (kidney, heart, lung) often epileptic seizures often intellectual disability Mutations in one of two tumorsuppressor genes TSC1 (Hamartin) (Chromosome 9) TSC2 (Tuberin) (Chromosome 16) 26
27 Tuberous Sclerosis Therapeutic Considerations specific AED VGB for BNS epilepsy disease modifying therapy mtor inhibition with Rapamycine/Everolimus -> reduction of volume of SEGA and angiomyolipoma, positive effects on epilepsy and development? 27
28 Diagnosis: From Phenotype to Genotype Gene Proteine Cell Metabolisma Cell Structure Tissue Organ Organsism Symptoms Syndrome 3rd order unspecific combination of symptoms Syndrome 2nd order (sequence) symptoms with pathogenetic relationship Syndrome 1st order direct relationship to genetic defect Genetic defect 28
29 Diagnosis: From phenotype to genotype Rarely diagnosis at first glance (e.g. Trisomy 21, Tuberous sclerosis) But usually complex relationship between genotype and phenotype due to pleiotropy and heterogeny. Detailed assessment of family history and phenotype (Development, complete medical history, clinical exmanination (neurologic, psychiatric, medical), study of the whole medical dossier)) Search in databases (Online Mendelian Inheritance in Man = OMIM, Human Phenotype ontology = HPO, Phenomizer Advice of a genetist in each case! Genetic Methods (F(luoreszens)-(I)n-(S)itu-(H)ybridization, sequencing of single genes) depend on suspected diagnoses Importance of epileptological phenotype in this process is different in different syndromes 29
30 Diagnosis: Genetic Screening Gene panels (epilepsy, mitochondrial disease): sequencing of up o several hundreds of candidate genes Array techniques (e.g. array comparative genomic hybridization). Detection of copy number variations (CNV) i.e. microdeletions, microduplications, rearranegments Whole exome sequencing Whole genome sequencing 30
31 Diagnosis: (Epilepsy) Gene Panel Lemke et al. Epilepsia. 2012; 53:
32 Diagnosis: Genetic Testing ID with epilepsy Genetic study in residents of swiss epilepsy center Informed consent of patients a/o guardian n= 89 (39 f, 49 m) Epilepsy gene panel, Array-CGH, (whole exome sequencng, whole genome sequencing) 32
33 Diagnosis: Genetic Testing ID with epilepsy Some preliminary results Mutations/variations of ion channel subunits genes (esp. sodium channels) are frequent F, * 1938 with SCN1A p.i1867t, mild ID, seizure free since many years with VPA Combinations of mutations/variants of ion channel subunit genes One male with MECP2 p.r453q (Rett Syndrome) A lot of findings with unknown significance 33
34 Summary/Perspectives Identification of a genetic entities underlying epilepsies and intellectual disability become increasingly important for therapy Modern genetic techniques (Panels, Array-CGH, whole exome/genome sequencing) will become cheap and easily accessible, but interpretation of data is and will remain often difficult Beside efficious anticonvulsive therapies antiepileptogenic and disease modifying therapies are appearing on the horizon New therapeutic options often contain expensive orphan drugs High costs for therapies require discussion society 34
35 Thanks Johannes Lemke, Erik Riesch and co-workers (Berne) Euroepinomics Consortium Patients, caregivers and guardians 35
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing
More informationEPILEPSY. Elaine Wirrell
EPILEPSY Elaine Wirrell Seizures are amongst the most common of neurological disorders in the pediatric age range. The incidence of new-onset epilepsy in children is approximately 40 per 100,000 per year
More informationNo relevant disclosures
No relevant disclosures - Epileptic Encephalopathy (EE): Epileptic activity itself contributes to cognitive and behavioural impairments - Developmental and Epileptic Encephalopathy (DEE): Impairments occur
More informationFebrile seizures. Olivier Dulac. Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663
Febrile seizures Olivier Dulac Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663 olivier.dulac@nck.aphp.fr Definition Seizures precipitated by fever that is not due to an intracranial infection
More informationEpileptogenesis: A Clinician s Perspective
Epileptogenesis: A Clinician s Perspective Samuel F Berkovic Epilepsy Research Centre, University of Melbourne Austin Health Epileptogenesis The process of development and sustaining the propensity to
More informationEpileptic syndrome in Neonates and Infants. Piradee Suwanpakdee, MD. Division of Neurology Department of Pediatrics Phramongkutklao Hospital
Epileptic syndrome in Neonates and Infants Piradee Suwanpakdee, MD. Division of Neurology Department of Pediatrics Phramongkutklao Hospital AGE SPECIFIC INCIDENCE OF EPILEPSY Hauser WA, et al. Epilepsia.
More informationDifficult to treat childhood epilepsy: Lessons from clinical case scenario
Difficult to treat childhood epilepsy: Lessons from clinical case scenario Surachai Likasitwattanakul, M.D. Department of Pediatrics Faculty of Medicine, Siriraj Hospital Natural history of Epilepsy Untreated
More informationPharmacogenetics & Epilepsy From a Clinical Perspective
Pharmacogenetics & Epilepsy From a Clinical Perspective Eylert Brodtkorb, Avd.. for Nevrologi og Klinisk nevrofysiologi St. Olav Hospital Trondheim, Norway Pharmacogenetics The study of the consequences
More informationErnie Somerville Prince of Wales Hospital EPILEPSY
Ernie Somerville Prince of Wales Hospital EPILEPSY Overview Classification New and old anti-epileptic drugs (AEDs) Neuropsychiatric side-effects Limbic encephalitis Non-drug therapies Therapeutic wishlist
More informationPondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies
Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Dan Lowenstein UCSF Department of Neurology and the UCSF Epilepsy Center To Cover: 1. Update
More informationApproach to the Genetic Diagnosis of Neurological Disorders
Approach to the Genetic Diagnosis of Neurological Disorders Dr Wendy Jones MBBS MRCP Great Ormond Street Hospital for Children National Hospital for Neurology and Neurosurgery What is a genetic diagnosis?
More informationDisclosure Age Hauser, Epilepsia 33:1992
Pediatric Epilepsy Syndromes Gregory Neal Barnes MD/PhD Assistant Professor of Neurology and Pediatrics Director, Pediatric Epilepsy Monitoring Unit Vanderbilt University Medical Center Disclosure Investigator:
More informationLevetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study
Seizure (2006) 15, 214 218 www.elsevier.com/locate/yseiz CASE REPORT Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study Angelo Labate a,b, Eleonora Colosimo
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2017 10/2018 10/2017 Description of Procedure or Service Description
More informationChildhood Epilepsy Syndromes. Epileptic Encephalopathies. Today s Discussion. Catastrophic Epilepsies of Childhood
CATASTROPHIC EPILEPSIES OF CHILDHOOD EPILEPTIC ENCEPHALOPATHIES Dean Sarco, MD Department of Neurology Kaiser Permanente Los Angeles Medical Center Childhood Epilepsy Syndromes Epilepsy Syndrome Grouping
More informationThe neonatal presentation of genetic epilepsies
The neonatal presentation of genetic epilepsies Maria Roberta Cilio, MD, PhD Professor, Neurology and Pediatrics Director of Research, UCSF Epilepsy Center Director, Neonatal Neuromonitoring and Epilepsy
More informationJULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology
JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic
More informationNeuromuscular Disease(2) Epilepsy. Department of Pediatrics Soochow University Affiliated Children s Hospital
Neuromuscular Disease(2) Epilepsy Department of Pediatrics Soochow University Affiliated Children s Hospital Seizures (p130) Main contents: 1) Emphasize the clinical features of epileptic seizure and epilepsy.
More informationChildren Are Not Just Small Adults Choosing AEDs in Children
Children Are Not Just Small Adults Choosing AEDs in Children Natrujee Wiwattanadittakun, MD Neurology division, Department of Pediatrics, Chiang Mai University Hospital, Chiang Mai University 20 th July,
More informationEpilepsy management What, when and how?
Epilepsy management What, when and how? J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children, London, & National Centre for Young People with Epilepsy, Lingfield, UK What
More informationDravet syndrome : Clinical presentation, genetic investigation and anti-seizure medication. Bradley Osterman MD, FRCPC, CSCN
Dravet syndrome : Clinical presentation, genetic investigation and anti-seizure medication Bradley Osterman MD, FRCPC, CSCN Objectives Learn about the typical early clinical presentation of Dravet syndrome
More informationWhat s the Human Genome Project Got to Do with Developmental Disabilities?
What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Epileptic encephalopathy, early infantile 4. OMIM number for disease 612164 Disease
More informationEpilepsy in the Primary School Aged Child
Epilepsy in Primary School Aged Child Deepak Gill Department of Neurology and Neurosurgery The Children s Hospital at Westmead CHERI Research Forum 15 July 2005 Overview The School Age Child and Epilepsy
More informationKetogenic Diet therapy in Myoclonic-Atonic Epilepsy (MAE)
KD therapy in epilepsy syndromes Ketogenic Diet therapy in Myoclonic-Atonic Epilepsy (MAE) Hirokazu Oguni, MD Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan Epilepsy Center, TMG
More informationDr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium
Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Sarah Weckhuysen No relevant financial relationships with any commercial interests.
More informationCurrent views on epilepsy management
Current views on epilepsy management J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children NHS Foundation Trust, London & Young Epilepsy, Lingfield, UK What are our current
More informationEpilepsy. Presented By: Stan Andrisse
Epilepsy Presented By: Stan Andrisse What Is Epilepsy Chronic Neurological Disorder Characterized by seizures Young children or elderly Developing countries Famous Cases Socrates Muhammad Aristotle Joan
More informationContemporary Developments in Childhood Epilepsy Management. Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital
Contemporary Developments in Childhood Epilepsy Management Olivia O Mahony, Cork University Hospital, Cork, and Mercy University Hospital Developments in Epilepsy Care Standardised epilepsy care using
More informationEpilepsy Syndromes: Where does Dravet Syndrome fit in?
Epilepsy Syndromes: Where does Dravet Syndrome fit in? Scott Demarest MD Assistant Professor, Departments of Pediatrics and Neurology University of Colorado School of Medicine Children's Hospital Colorado
More informationChildhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary
Childhood epilepsy: the biochemical epilepsies Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary Definitions Epileptic Seizure Manifestation(s) of epileptic (excessive and/or
More informationEpilepsy in Children
Epilepsy in Children Elizabeth A., MD, PhD Director, Pediatric Epilepsy Service Director, Carol and James Herscot Center for Tuberous Sclerosis Complex Massachusetts General Hospital Associate Professor
More informationMedical Policy. MP Genetic Testing for Epilepsy
Medical Policy MP 2.04.109 BCBSA Ref. Policy: 2.04.109 Last Review: 02/26/2018 Effective Date: 02/26/2018 Section: Medicine Related Policies 2.04.81 Genetic Testing for Rett Syndrome 2.04.83 Genetic Testing
More informationRevealing the mechanisms of epileptogenesis to design innovative treatments what are the tools?
Revealing the mechanisms of epileptogenesis to design innovative treatments what are the tools? Holger Lerche Dept. of Neurology and Epileptology Hertie Institute for Clinical Brain Research University
More informationRetrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients
Acta neurol. belg., 2000, 100, 171-176 Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients J. THIJS, H. VERHELST,
More informationRevisiting the Ketogenic Diet and Related Therapies in the Modern Era
Revisiting the Ketogenic Diet and Related Therapies in the Modern Era Heung Dong Kim M.D., Ph.D. Pediatric Epilepsy Clinic, Division of Pediatric Neurology Severance Children s Hospital Yonsei University
More informationEvaluation and management of drug-resistant epilepsy
Evaluation and management of drug-resistant epilepsy Fateme Jahanshahifar Supervised by: Professor Najafi INTRODUCTION 20 to 40 % of patients with epilepsy are likely to have refractory epilepsy. a substantive
More information13th ECE - Programme at a Glance
Neurobiology 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday 27th August
More information13th ECE Vienna - PROGRAMME AT A GLANCE
Neurobiology 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday 27th August
More informationClassification of Epilepsy: What s new? A/Professor Annie Bye
Classification of Epilepsy: What s new? A/Professor Annie Bye The following material on the new epilepsy classification is based on the following 3 papers: Scheffer et al. ILAE classification of the epilepsies:
More informationSETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017
SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017 1. The Epilepsy Genetic Diagnostic & Counselling Service at King s Health Partners Professor Deb Pal PhD MRCP (Consultant) deb.pal@nhs.net
More informationEpilepsy in the developing brain
Epilepsy in the developing brain Dr Katherine Howell* Neurologist, Royal Children s Hospital Melbourne Clinician-Scientist Fellow, Murdoch Children s Research Institute Honorary Senior Fellow, University
More informationEEG in Epileptic Syndrome
EEG in Epileptic Syndrome Surachai Likasitwattanakul, M.D. Division of Neurology, Department of Pediatrics Faculty of Medicine, Siriraj Hospital Mahidol University Epileptic syndrome Electroclinical syndrome
More informationDisease-Modifying, Anti-Epileptogenic, and Neuroprotective Effects of the Ketogenic Diet: Clinical Implications
Disease-Modifying, Anti-Epileptogenic, and Neuroprotective Effects of the Ketogenic Diet: Clinical Implications Special Lecture 6 th Global Symposium on Ketogenic Therapies for Neurological Disorders Jeju,
More informationIntegration of Next-Generation Sequencing into Epilepsy Clinical Care. Michelle Demos University of British Columbia BC Children s Hospital
Integration of Next-Generation Sequencing into Epilepsy Clinical Care Michelle Demos University of British Columbia BC Children s Hospital No Disclosures Learning Objectives To review: the impact of using
More informationAntiepileptic agents
Antiepileptic agents Excessive excitability of neurons in the CNS Abnormal function of ion channels Spread through neural networks Abnormal neural activity leads to abnormal motor activity Suppression
More informationEpilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie
Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie dr. Hannah Stamberger prof. dr. Peter De Jonghe Neurogenetics group, DMG, VIB http://www.molgen.vib-ua.be Disclosures
More information13th ECE Vienna - PROGRAMME AT A GLANCE
Neurobiology Symposium 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday
More informationThe Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012
The Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012 Tracy Dixon-Salazar, Ph.D. University of California, San Diego American Epilepsy Society Annual Meeting 1 Disclosure
More informationPaediatric Epilepsy Update N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y
Paediatric Epilepsy Update 2018 N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y Epilepsy Service CUH ~550 children New diagnosis-education, support, clinic follow up Epilepsy
More informationPharmacological Treatment of Non-Lesional Epilepsy December 8, 2013
Pharmacological Treatment of Non-Lesional Epilepsy December 8, 2013 Michael Privitera, MD Professor of Neurology University of Cincinnati, Neuroscience Institute American Epilepsy Society Annual Meeting
More informationPediatric Epilepsy Care in Milwaukee
Pediatric Epilepsy Care in Milwaukee Priya Monrad, MD Assistant Professor, Pediatric Neurology and Epilepsy Children s Hospital of Wisconsin Disclosures I have no relevant financial relationships to disclose.
More informationEpi4K. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):
Epi4K Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):1457-67. Genetics of Epileptic Encephalopathies Infantile Spasms (IS) 1 in 3000 live births and onset between 4-12
More informationTherapeutic strategies in the choice of antiepileptic drugs
Acta neurol. belg., 2002, 102, 6-10 Original articles Therapeutic strategies in the choice of antiepileptic drugs V. DE BORCHGRAVE, V. DELVAUX, M. DE TOURCHANINOFF, J.M. DUBRU, S. GHARIANI, Th. GRISAR,
More informationUpdate in Clinical Guidelines in Epilepsy
Why We Need Clinical Guidelines? Clinician needs advice! Update in Clinical Guidelines in Epilepsy Charcrin Nabangchang, M.D. Phramongkutklao College of Medicine Tiamkao S, Neurology Asia2013 Why We Need
More informationEpilepsy T.I.A. Cataplexy. Nonepileptic seizure. syncope. Dystonia. Epilepsy & other attack disorders Overview
: Clinical presentation and management Markus Reuber Professor of Clinical Neurology Academic Neurology Unit University of Sheffield, Royal Hallamshire Hospital. Is it epilepsy? Overview Common attack
More informationOverview of the epilepsies of childhood and comorbidities
Overview of the epilepsies of childhood and comorbidities Dr Amy McTague BRC Catalyst Fellow/Honorary Consultant Paediatric Neurologist UCL Great Ormond Street Institute of Child Health Epilepsy is a common
More informationSuccessful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report
*Manuscript Click here to view linked References Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report Thompson AGB 1, Cock HR 1,2. 1 St George s University
More informationAutism & Epilepsy: Which Comes First?
Autism & Epilepsy: Which Comes First? December 6, 2011 Roberto Tuchman, M.D. Director, Autism and Neurodevelopment Program Miami Children s Hospital Dan Marino Center Clinical Professor of Neurology and
More informationSeizure medications An overview
Seizure medications An overview Andrew Zillgitt, DO Staff Neurologist Comprehensive Epilepsy Center Department of Neurology Henry Ford Hospital None Disclosures Objectives A lot to review!!!!! Look at
More informationWho Gets Epilepsy? Etiologies and Risk Factors for Seizures. David Spencer, MD Professor of Neurology Director, OHSU Epilepsy Center Portland, OR
Who Gets Epilepsy? Etiologies and Risk Factors for Seizures David Spencer, MD Professor of Neurology Director, OHSU Epilepsy Center Portland, OR Epidemiology Risk Factors Febrile seizures CNS infection
More informationSeizures and the Epilepsies, Epidemiology, Classification, and Genetics
Seizures and the Epilepsies, Epidemiology, Classification, and Genetics Gregory L. Holmes Department of Neurological Sciences University of Vermont College of Medicine Burlington, Vermont Infantile + +
More informationGanaxolone as a Treatment for Drug-Resistant Epilepsy in Children
Ganaxolone as a Treatment for Drug-Resistant Epilepsy in Children ANTIEPILEPTIC DRUG and DEVICE TRIALS XIII May 13-15, 2015 Turnberry Isle Miami Hotel Gail M. Farfel, PhD Chief Development & Regulatory
More informationNASDAQ: ZGNX. Company Presentation. October 2017
NASDAQ: ZGNX Company Presentation October 2017 2 Forward Looking Statement Zogenix cautions you that statements included in this presentation that are not a description of historical facts are forward-looking
More informationDisclosure. Learning Objectives
Linda D. Leary, M.D. Associate Clinical Professor of Pediatrics & Neurology South Texas Comprehensive Epilepsy Center UT Health Science Center San Antonio Disclosure Linda D. Leary, M.D. discloses the
More informationManagement of Neonatal Seizures
Management of Neonatal Seizures Manal E. Moustafa Assistant Professor of Pediatric Neurology and Epilepsy Children s Healthcare of Atlanta/Emory University Disclosures I have none! 1 Objectives Recognition
More informationEpilepsy and EEG in Clinical Practice
Mayo School of Professional Development Epilepsy and EEG in Clinical Practice November 10-12, 2016 Hard Rock Hotel at Universal Orlando Orlando, FL Course Directors Jeffrey Britton, MD and William Tatum,
More informationEpidiolex in Dravet Syndrome and Lennox- Gestaut Syndrome (LGS) 27 September 2018 Presented by: Giuliana Campo 2019 PharmD Candidate 1
Epidiolex in Dravet Syndrome and Lennox- Gestaut Syndrome (LGS) 27 September 2018 Presented by: Giuliana Campo 2019 PharmD Candidate 1 Objectives To understand the epidemiology and pathophysiology of LGS
More informationChildhood Epilepsy - Overview & Update
Childhood Epilepsy - Overview & Update Nicholas Allen Dept. Paediatrics Mar 2016 NO DISCLOSURES Videos 1 Outline: Childhood Epilepsy What is it? How do we classify it? How do we diagnose it? How do we
More informationGENCODYS Patient Meeting. Saturday the 1 st of November 2014, Berlin
GENCODYS Patient Meeting Saturday the 1 st of November 2014, Berlin About GENCODYS Cognitive disorders can be caused by environmental factors as well as genetic factors. At the moment a definite diagnosis
More informationTHIAMINE TRANSPORTER TYPE 2 DEFICIENCY
THIAMINE TRANSPORTER TYPE 2 DEFICIENCY WHAT IS THE THIAMINE TRANSPORTER TYPE 2 DEFICIENCY (hthtr2)? The thiamine transporter type 2 deficiency (hthtr2) is a inborn error of thiamine metabolism caused by
More informationEpilepsy Genetics. Table of Contents. Author Information 1 Introduction 2
Table of Contents Author Information 1 Introduction 2 DEFINITIONS 2 INDICATIONS AND TECHNIQUES USED IN THE GENETIC EVALUATION OF EPILEPSY 4 PATHOPHYSIOLOGICAL MECHANISMS 10 GENETIC BASIS OF SPECIFIC EPILEPSY
More informationChronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University
Chronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University Sanaa 2009 Points of Discussion Prevalence compared to focal epilepsy Adult form Status
More informationExpanding spectrum of SCN1A-related phenotype with novel mutations
The Turkish Journal of Pediatrics 2017; 59: 570-575 DOI: 10.24953/turkjped.2017.05.010 Expanding spectrum of SCN1A-related phenotype with novel mutations Semra Hız-Kurul 1, Semra Gürsoy 2, Müge Ayanoğlu
More informationResearch Article Febrile Seizures and Febrile Remissions in Epilepsy in Children: Two Sides of the Same Process?
Cronicon OPEN ACCESS PAEDIATRICS Research Article Febrile Seizures and Febrile Remissions in Epilepsy in Children: Two Sides of the Same Process? Leanid Shalkevich 1 * 1 Department of Child Neurology,
More informationAED Treatment Approaches. David Spencer, MD Director, OHSU Epilepsy Center Professor, Department of Neurology
AED Treatment Approaches David Spencer, MD Director, OHSU Epilepsy Center Professor, Department of Neurology Audience Response Keypads Please utilize the keypad at your table to answer questions throughout
More informationWhen to start, which drugs and when to stop
When to start, which drugs and when to stop Dr. Suthida Yenjun, MD. PMK Epilepsy Annual Meeting 2016 The main factors to consider in making the decision The risk for recurrent seizures, which varies based
More informationStaging of Seizures According to Current Classification Systems December 10, 2013
Staging of Seizures According to Current Classification Systems December 10, 2013 Elinor Ben-Menachem, M.D.,Ph.D, Instituet of Clinical Neuroscience and Physiology, Sahlgren Academy, Goteborg University,
More informationClassification of Seizures. Generalized Epilepsies. Classification of Seizures. Classification of Seizures. Bassel F. Shneker
Classification of Seizures Generalized Epilepsies Bassel F. Shneker Traditionally divided into grand mal and petit mal seizures ILAE classification of epileptic seizures in 1981 based on clinical observation
More information2 nd Line Treatments for Dravet. Eric BJ Ségal, MD Northeast Regional Epilepsy Group
2 nd Line Treatments for Dravet Eric BJ Ségal, MD Northeast Regional Epilepsy Group Disclosures Accepted honoraria from Greenwich Pharmaceuticals, Zogenix, Eisai, Lundbeck, Lineagen. Overview Evidence
More informationUnderstanding and treating gait abnormality in Dravet syndrome
Understanding and treating gait abnormality in Dravet syndrome Anne Stratton, MD, FAAP, FAAPMR Biennial Dravet Syndrome Foundation Family and Professional Conference July 19-22, 2018 Disclosures I have
More informationNewcastle Mitochondrial Disease Guidelines
Newcastle Mitochondrial Disease Guidelines Epilepsy in Adult Mitochondrial Disease: Investigation and Management First published August 2010 Updated January 2013 1 Contents Introduction 3 Patient Centered
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationDravet syndrome with an exceptionally good seizure outcome in two adolescents
Clinical commentary Epileptic Disord 2011; 13 (3): 340-4 Dravet syndrome with an exceptionally good seizure outcome in two adolescents Katsuhiro Kobayashi 1, Iori Ohmori 2, Mamoru Ouchida 3, Yoko Ohtsuka
More informationAMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE
SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE 2014 Content Blueprint (November 26, 2012) Number of questions: 200 I. Classification 7 9% II. Routine EEG 16 20% III. Evaluation 22 26% IV.
More informationEpilepsy. Seizures and Epilepsy. Buccal Midazolam vs. Rectal Diazepam for Serial Seizures. Epilepsy and Seizures 6/18/2008
Seizures and Epilepsy Paul Garcia, M.D. UCSF Epilepsy Epileptic seizure: the physical manifestation of aberrant firing of brain cells Epilepsy: the tendency to recurrent, unprovoked epileptic seizures
More informationDoes AED Prophylaxis Work in Posttraumatic Epilepsy December 2, 2012
Does AED Prophylaxis Work in Posttraumatic Epilepsy December 2, 2012 Marc A. Dichter, MD, PhD University of Pennsylvania American Epilepsy Society Annual Meeting Disclosure Name of Commercial Interest
More informationDo seizures beget seizures?
Does MTLE cause progressive neurocognitive damage? Andrew Bleasel Westmead Do seizures beget seizures? The tendency of the disease is toward self-perpetuation; each attack facilitates occurrence of another
More informationAll visits for patients with diagnosis of epilepsy. Denominator Statement Denominator Exceptions
Measure 2: Etiology, Seizure Type, or Epilepsy Syndrome Measure Description Percent of all visits for patients with a diagnosis of with seizure type and etiology or syndrome documented OR testing* ordered
More informationEpilepsy 101. Russell P. Saneto, DO, PhD. Seattle Children s Hospital/University of Washington November 2011
Epilepsy 101 Russell P. Saneto, DO, PhD Seattle Children s Hospital/University of Washington November 2011 Specific Aims How do we define epilepsy? Do seizures equal epilepsy? What are seizures? Seizure
More informationMutations of Ion Channels in Genetic Epilepsies
Mutations of Ion Channels in Genetic Epilepsies Massimo Mantegazza, Raffaella Rusconi and Sandrine Cestèle Abstract Epileptogenic mutations have been identified in several ion channel genes, leading to
More informationThe Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician
The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician Part VII Recent Advances in the Genetics of Autism Spectrum Disorders Abha R. Gupta, MD, PhD Jointly
More informationlevetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd
Scottish Medicines Consortium Resubmission levetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd 11 January 2008 The Scottish Medicines
More informationClinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)
Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan) Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency
More informationAnticonvulsants Antiseizure
Anticonvulsants Antiseizure Seizure disorders Head trauma Stroke Drugs (overdose, withdrawal) Brain tumor Encephalitis/ Meningitis High fever Hypoglycemia Hypocalcemia Hypoxia genetic factors Epileptic
More informationElectroclinical Syndromes Epilepsy Syndromes. Angel W. Hernandez, MD Division Chief, Neurosciences Helen DeVos Children s Hospital Grand Rapids, MI
Electroclinical Syndromes Epilepsy Syndromes Angel W. Hernandez, MD Division Chief, Neurosciences Helen DeVos Children s Hospital Grand Rapids, MI Disclosures Research Grants: NIH (NINDS) Lundbeck GW Pharma
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationAPPENDIX S. Removed sections from original guideline. 1.1 Pharmacological treatment Introduction
00 0 APPENDIX S Removed sections from original guideline. Pharmacological treatment.. Introduction The evidence base for the newer AEDs (gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine,
More informationEpilepsy and Epileptic Seizures
Epilepsy and Epileptic Seizures Petr Marusič Dpt. of Neurology Charles University, Second Faculty of Medicine Motol University Hospital Diagnosis Steps Differentiation of nonepileptic events Seizure classification
More informationTest Information Sheet
Genetic Testing for Epilepsy: Childhood Epilepsy Panel Sequence Analysis and Exon-Level Deletion/Duplication Testing of 58 Genes Panel Gene List: SL, CACNA1A, CDKL5, CHD2, CHRNA2, CHRNA4, CHRNA7*, CHRNB2,
More information